Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Blood Protein Measurement
|
2575 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||
Angle Closure Glaucoma
|
56 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.020 | 1.000 | 2 | 2009 | 2020 | |||||
Coronary Artery Disease
|
1577 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.020 | 1.000 | 2 | 2010 | 2012 | |||||
Neoplasm Metastasis
|
327 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.020 | 1.000 | 2 | 2005 | 2007 | |||||
Primary angle-closure glaucoma
|
55 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.020 | 1.000 | 2 | 2009 | 2020 | |||||
Alzheimer's Disease
|
1843 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1 | 2005 | 2005 | ||||||
Behcet Syndrome
|
243 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Bladder Neoplasm
|
281 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Carcinoma of bladder
|
309 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Carcinoma of lung
|
1204 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Colorectal Carcinoma
|
1962 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1 | 2012 | 2012 | ||||||
Endometriosis
|
274 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Gallbladder Carcinoma
|
75 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1 | 2014 | 2014 | ||||||
Giant Cell Arteritis
|
78 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Malignant neoplasm of gallbladder
|
81 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1 | 2014 | 2014 | ||||||
Malignant neoplasm of lung
|
1142 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Malignant neoplasm of urinary bladder
|
316 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Primary malignant neoplasm of lung
|
981 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Squamous cell carcinoma of esophagus
|
329 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Stage 0 Gallbladder Cancer AJCC v8
|
56 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1 | 2014 | 2014 | ||||||
Stage IIA Gallbladder Cancer AJCC v8
|
56 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1 | 2014 | 2014 | ||||||
Stage IIB Gallbladder Cancer AJCC v8
|
56 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1 | 2014 | 2014 | ||||||
Stage III Gallbladder Cancer AJCC v8
|
56 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1 | 2014 | 2014 | ||||||
Stage IV Gallbladder Cancer AJCC v8
|
56 | 0.667 | 0.520 | 20 | 46013767 | missense variant | G/C;T | snv | 0.88; 1.6E-05 | 0.010 | 1 | 2014 | 2014 |